Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Neoplasm Metastasis 2Melanoma 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Urothelial Cancer 1Synovitis, Pigmented Villonodular 1Solid Tumor 1Skin Neoplasms 1Rectal Neoplasms 1Polyps 1Patient Satisfaction 1Pancreatitis 1Pancreatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Acute 1Glioma 1Diverticulosis, Colonic 1Choledocholithiasis 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Carcinoma 1Brain Neoplasms 1Brain Diseases 1Anxiety Disorders 1

Interventions

Midazolam 1Meperidine 1Etomidate 1Duodenoscopes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Choledocholithiasis × Midazolam × Clear all
NCT02027311 2015-06-29

Etomidate vs. Midazolam for Sedation During ERCP

Cheju Halla General Hospital

Phase 4 Completed
63 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms, Pancreatitis, Cholangiocarcinoma, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡